Skip to main content

Advertisement

Fig. 3 | Clinical Epigenetics

Fig. 3

From: SLCO4C1 promoter methylation is a potential biomarker for prognosis associated with biochemical recurrence-free survival after radical prostatectomy

Fig. 3

Association of four CpG sites methylation and SLCO4C1 mRNA expression in TCGA. a Association of cg06480736 methylation and mRNA expression. b Association of cg19774478 methylation and mRNA expression. c Association of cg19788741 methylation and mRNA expression. d Association of cg22149516 methylation and mRNA expression

Back to article page